Skip to main content
KURE logo
KURE
(NYSEARCA)
KraneShares MSCI All China Health Care Index ETF
$17.49-- (--)
Loading... - Market loading

KURE ETF: KraneShares MSCI All China Health Care Index ETF - Price, Holdings & Analysis

KraneShares MSCI All China Health Care Index ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$16.65 - $17.02
52-Week High$21.88
52-Week Low$14.38
Open$16.90
Volume54.52K
Average Volume (3M)82.41K
Assets (AUM)68.95M
Expense Ratio0.65%
Total Holdings50
Inception DateJan 31, 2018
1 Day Change-0.49%
1 Month Change21.22%
6 Month Change-5.41%
YTD Change2.47%
1 Year Change-5.66%
52-Week Change-4.71%
5 Year Change-58.71%
50-Day MA$16.04
200-Day MA$17.75
RSI55.20
Stochastic %K53.49
Stochastic %D82.55
Annual Dividend$0.72
Dividend Yield4.01%
Last Dividend Ex-DateDec 23, 2026
Dividend Growth YoY288.59%
Years Dividend Growth3

Frequently Asked Questions About KraneShares MSCI All China Health Care Index ETF

What is the current price of KURE?

The latest KURE price is $16.86. The 52-week range is $14.38–$21.88. KURE has returned -4.7% over the past 52 weeks.

What is the expense ratio for KURE?

KURE's annual expense ratio is 0.65%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does KURE pay dividends?

Yes, KURE pays a 4.01% dividend yield. The last ex-dividend date was 2026-12-23. View full dividend history in the Dividends section.

What are the top holdings of KURE?

KURE's largest holdings are BeOne Medicines AG (9.2%), Innovent Biologics, Inc. (8.4%), WuXi Biologics (7.6%) (combined weight: 25.2%). The fund holds 50 total positions. View the complete portfolio breakdown in the Holdings section.

How does KURE compare to similar ETFs?

Compare KURE (0.65% expense ratio, $69M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.